Search

(Bloomberg) -- Sign up for the New Economy Daily newsletter, follow us @economics and subscribe to our podcast. Instead, a lack of access to vaccines threatens to make things worse Asian economies have been slow in rolling out vaccination programs after early successes in controlling the coronavirus, leaving the region vulnerable to further economic damage, writes Bloomberg Economics Chang Shu South Korea's early trade data show exports are set to surge in May as vaccinations allow a broader reopening of major economies Australia's relentless recovery struck an air pocket as sentiment retreated and employment fell for the first time in seven months ©2021 Bloomberg L.P. [Extracted from the article]

Japan has found a variant of the coronavirus similar to strains discovered in Britain and South Africa. Japan Says It Found New Coronavirus Variant (6:32 a.m. NY) Japan's National Institute of Infectious Diseases said authorities have found a new strain of the coronavirus in four passengers arriving from Brazil. [Extracted from the article]

Japan has found a variant of the coronavirus similar to strains discovered in Britain and South Africa. Japan Weighs Approving Pfizer Vaccine for Ages 16 and Up: NHK (10:13 a.m. HK) Japan's government is considering approving Pfizer Inc.'s Covid-19 vaccine for use by individuals aged 16 and above, broadcaster NHK reported. [Extracted from the article]

The U.K. is on course to meet its target for vaccines, but faces pressure on the health service due to surging cases, Health Secretary Matt Hancock said. Pfizer and BioNTech SE, which applied for regulatory approval of their coronavirus vaccine in Japan last month, have agreed to provide 120 million doses to the country in the first half of 2021. [Extracted from the article]

The U.K. is on the road to meeting its target for vaccines, but faces pressure on the health service due to surging cases, Health Secretary Matt Hancock said. Japan's government is reportedly considering approving Pfizer Inc.'s vaccine for use by individuals aged 16 years and above, while India will kickstart one of the world's largest coronavirus inoculation campaigns on Jan. 16. Pfizer and BioNTech SE, which applied for regulatory approval of their coronavirus vaccine in Japan last month, have agreed to provide 120 million doses to the country in the first half of 2021. [Extracted from the article]